Towards Healthcare
CDMO Services for Pharma and Biotech Market Expands in 2025 as Small Molecules...

CDMO Services for Pharma and Biotech Market Leads North America with 44.1% in 2024

Based on forecasts, the CDMO services for pharma and biotech market is expanding due to increasing outsourcing as well as rising cancer treatment approaches. North America led the market due to the presence of well-developed industries.     

  • Insight Code: 5801
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

FAQ's

The CDMO Services for Pharma and Biotech Market (2024–2034), driven by innovation in biologics, personalized medicine, and global outsourcing trends.

North America is currently leading the CDMO services for pharma and biotech market due to the presence of well-developed industries.

The CDMO services for pharma and biotech market includes six segments such as by service type, Shape, Pictureby molecule type,Shape, Picture Shape, Picture by phase, by end user, by therapeutic area, and by region.

Some key players include Lonza Group AG, Catalent Inc., Thermo Fisher Scientific (Patheon), and WuXi AppTec.

Key trends include rising accessibility and availability of Pb-212 generator platform and alpha isotopes, and innovation in biosimilars.

Oncology is the therapeutic area that dominates the market.

Increasing outsourcing is the factor that drives the market.

DCAT Value Chain Insights, Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.